Stereotactic Body Radiation Therapy (SBRT)
Treatment for Liver cancer due to NASH
Typical Dosage: 30-60 Gy in 3-5 fractions
Effectiveness
75%
Safety Score
50%
Clinical Trials
50
Participants
5K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
50
DangerousModerateSafe
Treatment Details
Dosage Range
30-60 Gy in 3-5 fractions
Time to Effect
weeks to months
Treatment Duration
1-5 fractions, typically 1 week
Evidence Quality
MODERATENumber Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$6,000
Side Effect Mgmt:$2,000
Total Annual:$38,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$70,000/QALY
QALYs Gained
1.5
Outcome-Based Costs
Cost per Responder
$47,500
Comparison vs TACE
Cost Difference
+$10,000/year
More expensive
QALY Difference
+0.20 QALYs
Better outcomes
Dominance
No dominance
Stereotactic Body Radiation Therapy (SBRT) Outcomes
for Liver cancer due to NASH
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+80%
Common Side Effects
Fatigue
+30%
Nausea/vomiting
+15%
Pain
+10%
Radiation-induced liver disease (RILD)
+7%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov